PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma

Online download statistics by month:

Online download statistics by month: October 2021 to March 2023

	Abstract	Full	Pdf
Oct 2021	457	461	165
Nov 2021	131	130	45
Dec 2021	128	128	34
Jan 2022	106	107	50
Feb 2022	59	60	28
Mar 2022	75	76	37
Apr 2022	65	66	29
May 2022	68	68	31
Jun 2022	70	73	19
Jul 2022	62	63	10
Aug 2022	78	80	21
Sep 2022	70	72	34
Oct 2022	61	61	33
Nov 2022	65	65	31
Dec 2022	42	45	18
Jan 2023	32	37	27
Feb 2023	55	55	10
Total	1624	1647	622